Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Tafasitamab
Open monograph to display formulary status.
No results found when searching the local formulary, see alternative searches below.
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Tafasitamab
Tafasitamab [Specialist Drug]
Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
No exact matches found - Possible matches - use with care.
Status
Description
Section
RED
Tofacitinib Xeljanz
®
Musculoskeletal and joint diseases, Drugs which suppress the rheumatic disease process, 10.01.03 Tablets
RED
Tofacitinib 5mg, 10mg Xeljanz
®
Gastro-intestinal system, Drugs affecting the immune response, 01.05.03 Tablets
Links found
NICE TA883: Tafasitamab with lenalidomide for treating relapsed or refractory diffuse large B-cell lymphoma (not recommended)